Zhejiang Cancer Hospital: Neoplasm Metastasis trials

The registry lists 10 Neoplasm Metastasis studies with Zhejiang Cancer Hospital as lead sponsor. 5 are open to participants now and 1 have results posted.

Phase 2 7Phase 3 1No phase 3(a study in two phases counts in both)

Studies

Open to participants first, then studies with results posted, then the rest; newest registration first within each.

• Cerebrospinal Fluid Cytology-guided Intrathecal Chemo-holiday Therapy for EGFR-positive NSCLC Leptomeningeal MetastasesNot yet recruitingNCT06861218Phase 2
• Tislelizumab Combined with Nab-Paclitaxel for First-Line Treatment of Advanced Triple-Negative Breast Cancer with Bone Metastasis，an Exploratory, Single-Arm, Multicenter Phase II Clinical StudyRecruitingNCT06538896Phase 2
• Sintilimab in Combination With S-1/Oxaliplatin With Nab-paclitaxel Intraperitoneal Infusion for Untreated Advanced Gastric Cancer With Malignant AscitesRecruitingNCT06046963Phase 2
• Effect of Zoledronic Acid Treatment on Bone-related Events in Breast Cancer Patients With Bone Metastases: a Prospective, Multicenter, Real-world StudyNot yet recruitingNCT05480189
• Oligo-metastases NPC Patients Received Radiation for Primary Tumors and Treatments for Metastatic LesionsRecruitingNCT03129412Phase 2
• CK19 Combined With Contrast-enhanced Ultrasound: a Prediction System on Axillary Lymph Node Metastasis in Breast CancerCompletedNCT02992067Results posted
• Camrelizumab Combined With Local Treatment in NSCLC Patients With BMStatus unknownNCT04291092Phase 2
• A Prospective Validation Cohort Study of a Prediction System on nSLN Metastasis in Early Breast CancerStatus unknownNCT03280134Not applicable
• Treatment Patients With Pulmonary Metastasis of Liver Cancer With Apatinib Combination With TACE: a Clinical StudyStatus unknownNCT02702323Phase 2/3
• Phase II Trial of Double Dose of Icotinib in Treating Brain Metastases From Non-small Cell Lung CancerStatus unknownNCT01688713Phase 2